In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.
Shares of the gene-sequencing firm ... from consumables and software services. With a modest market cap of £1.4bn, the firm could become a takeover target. However, it can be dangerous to invest on ...
J.P. Morgan Healthcare Conference -- NVIDIA today announced new partnerships to transform the $10 trillion healthcare and life sciences industry by accelerating ...
The Protein Sequencing Companytm, announces the launch of Platinum® Pro, its latest benchtop sequencer that sets a new standard in protein analysis. Designed to redefine efficiency ...